Zheng Lihua, Shi Yuying, Zhi Congcong, Yu Qiuxiang, Li Xin, Wu Shanshan, Zhang Wen, Liu Yanjun, Huang Zichen
Proctology Department, China-Japan Hospital, Beijing, China.
National Clinical Research Center of Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Ann Transl Med. 2020 Oct;8(19):1236. doi: 10.21037/atm-20-6123.
Achieving a complete cure while maintaining continence constitutes a considerable challenge in the treatment of patients with high anal fistula. This study aimed to evaluate the effectiveness of loose combined cutting seton (LCCS) for treating patients with high intersphincteric fistula.
Consecutive patients with high intersphincteric fistula who underwent LCCS were retrospectively enrolled. Patient data including demographics, medical history, comorbidities, details of the fistula, operative procedure, and prognosis were collected. Postoperative pain was assessed using a visual analog scale (VAS), which ranged from 0 (no pain) to 10 (extremely severe pain). The severity of fecal incontinence was assessed using the Wexner Continence Grading Scale, with a total score ranging from 0 (no incontinence) to 20 (complete incontinence). The primary outcome was the healing rate of fistula. Secondary outcomes included the recurrence rate of fistula and the severity of fecal incontinence.
The 22 patients (male: female =18:4) in our study had a median follow-up of 55 (range, 32-568) days. The healing rate was 100%, and none of the patients experienced fistula recurrence. At the follow-up visit, 19 patients (86.4%) reported no fecal incontinence. The median total Wexner score was 0. 95.5% patients had VAS score of 0 and only 1 patient (4.5%) had a VAS score of 1, which indicated a low level of postoperative pain.
LCCS achieved a high healing rate with an increased level of continence, as well as a low level of postoperative pain, in most patients with high anal fistula in our study. Further randomized controlled trials are needed to confirm the effectiveness of this novel seton-based technique.
在高位肛瘘患者的治疗中,实现完全治愈并同时保持控便功能是一项颇具挑战的任务。本研究旨在评估松散联合切割挂线术(LCCS)治疗高位括约肌间瘘患者的有效性。
回顾性纳入连续接受LCCS治疗的高位括约肌间瘘患者。收集患者的人口统计学资料、病史、合并症、肛瘘细节、手术过程及预后等数据。采用视觉模拟评分法(VAS)评估术后疼痛,范围为0(无疼痛)至10(极度剧痛)。采用韦克斯纳控便分级量表评估大便失禁的严重程度,总分范围为0(无失禁)至20(完全失禁)。主要结局指标为肛瘘愈合率。次要结局指标包括肛瘘复发率和大便失禁的严重程度。
本研究中的22例患者(男∶女 = 18∶4)中位随访时间为55(32 - 568)天。愈合率为100%,无患者出现肛瘘复发。随访时,19例患者(86.4%)报告无大便失禁。韦克斯纳总分中位数为0。95.5%的患者VAS评分为0,仅1例患者(4.5%)VAS评分为1,表明术后疼痛程度较低。
在本研究的大多数高位肛瘘患者中,松散联合切割挂线术实现了高愈合率、更高的控便水平以及较低的术后疼痛程度。需要进一步开展随机对照试验以证实这种基于新型挂线技术的有效性。